BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 25887188)

  • 1. Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma.
    Bolomsky A; Hose D; Schreder M; Seckinger A; Lipp S; Klein B; Heintel D; Ludwig H; Zojer N
    J Hematol Oncol; 2015 Feb; 8():10. PubMed ID: 25887188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of Insulin-Like Growth Factor Binding Protein 7 Gene in Multiple Myeloma Cell Line and Methylation Regulation].
    Liu WH; Ma YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):813-817. PubMed ID: 28641641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation patterns of IGFBP7 in colon cancer cell lines are associated with levels of gene expression.
    Lin J; Lai M; Huang Q; Ma Y; Cui J; Ruan W
    J Pathol; 2007 May; 212(1):83-90. PubMed ID: 17334979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low expression of insulin-like growth factor binding protein 7 associated with poor prognosis in human glioma.
    Tian X; Zhang L; Sun L; Xue Y; Xie S
    J Int Med Res; 2014 Jun; 42(3):651-8. PubMed ID: 24743871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of IGF1-R overcomes IGFBP7-induced chemotherapy resistance in T-ALL.
    Bartram I; Erben U; Ortiz-Tanchez J; Blunert K; Schlee C; Neumann M; Heesch S; Baldus CD
    BMC Cancer; 2015 Oct; 15():663. PubMed ID: 26450156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGFBP7 plays a potential tumor suppressor role against colorectal carcinogenesis with its expression associated with DNA hypomethylation of exon 1.
    Ruan WJ; Lin J; Xu EP; Xu FY; Ma Y; Deng H; Huang Q; Lv BJ; Hu H; Cui J; Di MJ; Dong JK; Lai MD
    J Zhejiang Univ Sci B; 2006 Nov; 7(11):929-32. PubMed ID: 17048309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGFBP7 participates in the reciprocal interaction between acute lymphoblastic leukemia and BM stromal cells and in leukemia resistance to asparaginase.
    Laranjeira AB; de Vasconcellos JF; Sodek L; Spago MC; Fornazim MC; Tone LG; Brandalise SR; Nowill AE; Yunes JA
    Leukemia; 2012 May; 26(5):1001-11. PubMed ID: 22005787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased copy number of the interleukin-6 receptor gene is associated with adverse survival in multiple myeloma patients treated with autologous stem cell transplantation.
    Kim SY; Min HJ; Park HK; Oh B; Kim TY; She CJ; Hwang SM; Kim M; Kim HK; Kim I; Yoon SS; Park S; Kim BK; Lee JH; Lee DS;
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):810-20. PubMed ID: 21220034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGFBP7 promoter methylation and gene expression analysis in prostate cancer.
    Sullivan L; Murphy TM; Barrett C; Loftus B; Thornhill J; Lawler M; Hollywood D; Lynch T; Perry AS
    J Urol; 2012 Oct; 188(4):1354-60. PubMed ID: 22906661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGFBP7 is a p53 target gene inactivated in human lung cancer by DNA hypermethylation.
    Chen Y; Cui T; Knösel T; Yang L; Zöller K; Petersen I
    Lung Cancer; 2011 Jul; 73(1):38-44. PubMed ID: 21095038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of insulin-like growth factor-binding protein 7 on steroidogenesis in granulosa cells derived from equine chorionic gonadotropin-primed immature rat ovaries.
    Tamura K; Matsushita M; Endo A; Kutsukake M; Kogo H
    Biol Reprod; 2007 Sep; 77(3):485-91. PubMed ID: 17522074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome.
    Gambaro K; Quinn MC; Cáceres-Gorriti KY; Shapiro RS; Provencher D; Rahimi K; Mes-Masson AM; Tonin PN
    BMC Cancer; 2015 Mar; 15():135. PubMed ID: 25886299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of interleukin 16 in multiple myeloma.
    Atanackovic D; Hildebrandt Y; Templin J; Cao Y; Keller C; Panse J; Meyer S; Reinhard H; Bartels K; Lajmi N; Sezer O; Zander AR; Marx AH; Uhlig R; Zustin J; Bokemeyer C; Kröger N
    J Natl Cancer Inst; 2012 Jul; 104(13):1005-20. PubMed ID: 22745469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma-secreted factors induce IGFBP7 and angiogenesis by modulating Smad-2-dependent TGF-beta signaling.
    Pen A; Moreno MJ; Durocher Y; Deb-Rinker P; Stanimirovic DB
    Oncogene; 2008 Nov; 27(54):6834-44. PubMed ID: 18711401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Function and expression of insulin-like growth factor-binding protein 7 (IGFBP7) gene in childhood acute myeloid leukemia.
    Hu S; Chen R; Man X; Feng X; Cen J; Gu W; He H; Li J; Chai Y; Chen Z
    Pediatr Hematol Oncol; 2011 May; 28(4):279-87. PubMed ID: 21413833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of IGFBP7 in acute leukemia is regulated by DNA methylation.
    Heesch S; Bartram I; Neumann M; Reins J; Mossner M; Schlee C; Stroux A; Haferlach T; Goekbuget N; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
    Cancer Sci; 2011 Jan; 102(1):253-9. PubMed ID: 21040219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype.
    Suzuki H; Igarashi S; Nojima M; Maruyama R; Yamamoto E; Kai M; Akashi H; Watanabe Y; Yamamoto H; Sasaki Y; Itoh F; Imai K; Sugai T; Shen L; Issa JP; Shinomura Y; Tokino T; Toyota M
    Carcinogenesis; 2010 Mar; 31(3):342-9. PubMed ID: 19638426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGFBP7 downregulation is associated with tumor progression and clinical outcome in hepatocellular carcinoma.
    Tomimaru Y; Eguchi H; Wada H; Kobayashi S; Marubashi S; Tanemura M; Umeshita K; Kim T; Wakasa K; Doki Y; Mori M; Nagano H
    Int J Cancer; 2012 Jan; 130(2):319-27. PubMed ID: 21328580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load.
    Neben K; Jauch A; Hielscher T; Hillengass J; Lehners N; Seckinger A; Granzow M; Raab MS; Ho AD; Goldschmidt H; Hose D
    J Clin Oncol; 2013 Dec; 31(34):4325-32. PubMed ID: 24145347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.